Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Gaggle to Host Student Wellness Series of Webinars


News Image

“Even before the pandemic struck, modern-day students were experiencing a mental health crisis,” said Gaggle’s CEO and founder, Jeff Patterson. “It’s no longer enough to simply protect students in a physical sense. We have to consider the whole child from a social and emotional standpoint.”

With all the disruptions to students’ daily routines and the social isolation that many across the country are still experiencing, more attention than ever needs to be paid to their psychological well-being. This fall, Gaggle will host the Student Wellness Series: four webinars featuring experts on a variety of topics impacting the mental and physical well-being of today’s K-12 students.

“Even before the pandemic struck, modern-day students were experiencing a mental health crisis,” said Gaggle’s CEO and founder, Jeff Patterson. “Reports indicate that approximately 10 million young people between the ages of 13 and 18 are in need of professional help for a mental health condition. It’s no longer enough to simply protect students in a physical sense. We have to consider the whole child from a social and emotional standpoint.”

The Student Wellness Series will run from mid-October through mid-November. Interested educators can register for the free webinars by visiting https://news.gaggle.net/student-wellness-fall-2020. The schedule for the series is as follows:

Eating Disorders

October 13 at 4:00 PM ET

These complex conditions, which can seriously impact students’ mental and physical health, often require both medical and psychological intervention. Dr. Lisa Strohman, an expert on student mental health, will explain how eating disorders affect adolescents.

Incels

October 20 at 1:00 PM ET

Bruno Dias, the director of safety and security at Mansfield Independent School District in Texas, will lend his expertise on this topic.

Anxiety

November 2 at 1:00 PM ET

Anxiety and depression are on the rise, with 70% of teens seeing these issues as a major problem. Dr. Lisa Strohman will join attendees again for this session along with Christine Ravesi-Weinstein, an educational leader, mental health advocate, and author of “Anxious: Advocating for Students with Anxiety, Because What if it Turns Out Right?”

Cutting

November 17 at 1:00 PM ET

Students suffering from depression and anxiety may turn to cutting, a form of self-harm, as a way to release their pain and emotions. Dr. Lisa Strohman returns for the final installment of the Student Wellness Series.

For the past 21 years, Gaggle has been committed to helping K-12 districts manage student safety on school-provided technology. Using a powerful combination of technology and trained safety experts, the safety solution proactively assists districts around the clock in the prevention of student suicide, bullying, inappropriate behaviors, school violence, and other harmful situations. The company recently launched Gaggle Therapy, which matches students who need mental health support with counselors licensed in their state for weekly teletherapy sessions.

For more information about Gaggle, please visit http://www.gaggle.net and follow Gaggle on Twitter at @Gaggle_K12.

Share article on social media or email:



Villa Welcomes Infection Prevention Expert: Dr. Mia Taormina


News Image

Michelle Scherwinski, CNO, “We are honored Dr. Taormina has joined us. Our collective work is unending and our quality focus remains unwavering.”

Villa Healthcare, a leader in skilled nursing, would like to welcome Mia A. Taormina, DO, FACOI, as an Infection Prevention consultant for COVID-19 mitigation responses and general infection control principles and practices. Dr. Taormina is a double board certified physician in Internal Medicine and Infectious Disease with significant, relevant experience in infection control and antibiotic stewardship. She has been in practice for 13 years and is also a chair of an Infection Control Task Force in DuPage County and co-chair of the Medical Utilization Management Committee at AMITA Health. Dr. Taormina completed her education at Michigan State University and her residency and fellowship at Botsford Hospital where she specialized in infectious disease. Dr. Taormina was recognized as one of Chicago’s Top Docs in Infectious Disease and received recognition by Crain’s Chicago as a Healthcare Hero during this pandemic response.

Dr. Taormina’s role at Villa will include consultation with the 34 centers about all aspects of infection prevention and control, including COVID-19. Michelle Scherwinski, Chief Nursing Officer says, “We are honored Dr. Taormina has joined us. Our collective work is unending and our quality focus remains unwavering. The wealth of expertise and experience that she brings will enhance our infection control practices, implemented in-line with guidance from the CDC, CMS and the local health departments.”

We’re Villa, and we make people better. Of course, we’re focused on quality care and good outcomes. But we’re here to do so much more. Villa’s leadership has a vision of rising above the status quo—of never settling, and of shattering the old image of this industry. We’ve always wanted to be a part of something greater, and we’re making that a reality. Our commitment to our people, our environment and clinical programs will allow us to fulfill our mission of making people better. For more information, please visit http://www.VillaHC.com.

Share article on social media or email:

Struggling Businesses Don’t Have to Wait on Washington With the Release of Dave Chase’s Third Book


As the greatest healthcare crisis in modern history collides with a presidential election, Dave Chase, co-founder of Health Rosetta, a nonprofit dedicated to lowering healthcare costs and improving employer health plans, debuts today the release of his third book: Relocalizing Health: The Future of Health is Local, Open, and Independent https://www.amazon.com/dp/0999234366.

While businesses working to recover from the Covid-19 crisis may have high hopes that the upcoming election will bring them the relief they need, the reality is that it could be months before any potentially helpful measure is approved by a divided Congress. Businesses need financial relief now, and Relocalizing Health helps answer that call by providing readers with concrete, proven steps they, their employer and/or their local elected officials can take to lower healthcare costs and improve health outcomes in their communities.

“Relocalizing Health exposes the secret superpower of health care: the best product also saves the most money,” said Katy Talento, former White House Health Policy Advisor. “Imagine the joy of discovering the Health Rosetta revolution, upending conventional wisdom and inspiring employers and policy makers across the fruited plain. Relocalizing Health delivers these learnings in tangible, replicable detail, extending a hand of invitation to join the movement and make health care human again.”

Beginning with a historical look at how the American healthcare system devolved into dysfunction and profiteering, Relocalizing Health goes on to explains how healthcare prices have risen at a faster rate than wages and inflation, stolen from savings accounts and public programs, and – most importantly – how a grassroots movement by public and private sector leaders can put an end to this vicious cycle.

“Coming out of COVID, Relocalizing Health provides the hope and roadmap for how communities will recover better and stronger,” said Shawn Strash, former CEO of 21 hospitals. “It’s more clear than ever that the hospital structure of the last few decades won’t enable our communities to maximize their health and well-being.”

Not only does Chase’s book provide the steps the employers and local leaders can take today to start saving money and transform their local community, it also includes case studies of the Health Rosetta model at work.

“This stuff works,” said Dr. Garrison Bliss, inventor of Direct Primary Care. “If you want to live in this world, read Dave’s book and then do something to grab the reins yourself and get control of this problem.”

“Against all odds, real change is possible – no matter an employer’s location, industry, or size – if we refuse to wait on Washington and commit today to creating the lower-cost, high-quality healthcare system we all deserve,” says Chase.

Relocalizing Health is available for purchase at https://www.amazon.com/dp/0999234366. To learn more about Dave Chase and the nonprofit he co-founded, please visit healthrosetta.org.

ABOUT HEALTH ROSETTA

Health Rosetta is a nonprofit, LEED-like organization that accredits health benefits professionals and plans. Health Rosetta supports the movement to reform the dysfunctional American healthcare system by cutting out wasted spending in healthcare, improving healthcare benefits for workers, and empowering employers to regain control over health insurance plans.

Media Contact:

Ria Duffy

ria.duffy@pinkston.co

(703) 946-0327

Share article on social media or email:

Sam the Dog and BunBun make brushing teeth fun


Desert Essence's new plant-powered toothpaste gels for kids

Desert Essence’s new plant-powered gels for kids are safe to swallow.

When toothpaste is safe to swallow it’s easier to concentrate on good brushing techniques with children instead of worrying about harmful chemicals.

As if being quarantined with the kids for six months hasn’t been hard enough, bedtime routines like brushing teeth haven’t got any easier either. This October, though, thanks to BunBun and Sam the Dog, this battle may be won. Just in time for Dental Hygiene Month, Desert Essence is launching two new plant-powered gels that are safe to swallow. Tutti Frutti and Green Apple Watermelon flavors are specially formulated for ages 6 months to 6 years. Carrageenan-free and fluoride-free, the natural toothpastes feature colorful characters, BunBun and Sam the Dog, to encourage children to brush developing teeth and begin adopting healthy dental habits early in life.

Removing the worry of accidental swallowing of toothpaste, Desert Essence’s new gels help strengthen and protect developing teeth. As children learn to follow a dental care routine, brushing teeth at least twice a day, these soothing Aloe-based formulas help to gently and safely remove plaque from teeth and gums.

“When toothpaste is safe to swallow it’s easier to concentrate on good brushing techniques with children instead of worrying about harmful chemicals,” says Christine Allmer, Desert Essence’s marketing director. “BunBun and Sam the Dog can be used to make brushing teeth a fun activity, and the fruity flavors make it easier to introduce the toothbrush safely to younger children.”

Desert Essence’s BunBun and Sam the Dog recommend three top tips for Dental Hygiene Month:

1) Make brushing routines fun. Help children associate dental care with a song that lasts at least two minutes, so they learn how long to brush their teeth for.

2) Let children pick out a colorful toothbrush that is the right fit for their age and mouth size, and offer a choice of toothpaste flavors.

3) Set a great example by brushing, flossing and rinsing adult teeth with children present, and talk about the importance of good dental health for the whole family – even pets!

Desert Essence , a leader in the natural personal care space and #2 in the Oral Care market*, developed the children’s toothpastes in response to consumer requests. The ingredients include Aloe, which is fortified with antioxidants and enzymes, to provide powerfully soothing hydration. Xylitol, a natural sugar alternative extracted from plants and vegetables, helps fight plaque and bacteria along with regular brushing. Calcium Glycerophosphate, a form of calcium, helps strengthen developing teeth. Parents are encouraged to apply pea-size amount of toothpaste on a child’s toothbrush twice a day.

Made in the USA with globally sourced ingredients, Desert Essence’s new children’s toothpaste gels are also gluten-free and Cruelty-Free/ Leaping Bunny Certified. The products are available on the company web site, http://www.desertessence.com, and in select national retail stores. SRP is $4.99 for 4.7 oz.

Desert Essence was founded in 1978 and is a leader in natural personal care. The company draws its inspiration and ingredients from the desert, “a model of pristine balance and sustainability, where limited resources, if used responsibly, offer the body and spirit untold benefits.” Using nutrient‐rich desert botanicals revered in native cultures for their healing properties, like Tea Tree, Jojoba, Aloe, and Argan Oils, Desert Essence’s body, skin, and hair care products work in harmony with the body to soothe, nurture, and restore. True to its principle, the company works to ensure that both its products and practices reflect the serious commitment it has made to the health of the planet. Desert Essence is a Certified B-corp Corporation.

*Source: SPINscan Natural, 52 wks ending 6/14/20

Share article on social media or email:

MedZone’s Face Balm For Masks™ Chosen For Walmart Open Call Event


News Image

MedZone, an industry leader in sports medicine, skincare, anti-chafe and hygiene products was one of the brands chosen for Walmart’s seventh annual Open Call for small businesses. MedZone’s Face Balm for Masks™ has been selected as one of the 175 U.S. manufactured small businesses to advance to the next stage in the process to land on store and club shelves. The opportunity can range from a handful of local stores to supplying hundreds of stores and Sam’s Clubs as well as Walmart.com and Walmart Marketplace.

“Success at Walmart is something that most small businesses dream of. We are grateful for the positive feedback we received at the Open Call Event. Bringing Face Balm to people wearing masks is something our team is dedicated to. We are proud that our team could take feedback from a customer and turn it into a nationally known product that is helping people in these chaotic times.”

More than 4,800 U.S small and medium-sized businesses representing 49 states applied for the opportunity to pitch a Walmart merchant, a 44% increase in submissions from last year. Of the 4,800 businesses, 850 received their official invitations to pitch their products and 175 of those businesses were chosen to move forward after a 30-minute virtual one-on-one zoom session. In addition to the pitch meetings, the one-day program included a series of breakout sessions designed to inform, empower, and encourage business owners of all sizes. Further information can be found here.

The chosen product, Face Balm, is the first all-natural solution to help reduce chafing, chapped skin and friction caused by wearing face masks. On the heels of the successful launch of their line of high-quality hand sanitizers, MedZone moved quickly to bring this much needed product to the market for first responders, teachers, industrial workers, medical professionals as well as every day consumers who are now wearing masks regularly. Given the increased need and requirements to wear face masks globally, this product is applicable to many market segments. Face Balm brings comfort to those who are wearing face masks.

Face Balm has captured national attention on The Today Show, in addition to various prestigious digital outlets. The product was quickly developed and brought to market following inquiries from customers regarding ways to prevent irritation or ‘maskne’ by using other MedZone anti-chafe products. The team took the customers feedback and used their years of expertise to create a gentle, easy-to-apply formula made with natural ingredients such as coconut oil, sweet almond oil, shea butter, aloe extract, avocado, jojoba and olive oil, making it great for all skin types. This entrepreneurial mindset and ability to act fast to market conditions is something MedZone has come to be known for in the industry.

MedZone has donated products to various hospitals around the country to help medical teams and first responders during this chaotic time. Plans are being made to contribute a portion of sales to charitable organizations, previously the company engaged in social responsibility programs for its hand sanitizer products. Face Balm is $11.97 (3 pack) and available at http://www.facebalm.com.

About MedZone

The mission of MedZone® is to make EveryBODY Feel Better. MedZone products work to prevent, treat and manage aches, pains, discomforts, wounds, hand hygiene and skin-chafing issues for individuals in sports, industrial settings and recreational activities. Our products were initially designed in 2001 based on requests from medical professionals, athletes and U.S. Military. Over the years the products have been adapted to work for athletes, active people, law enforcement, military and for certain healthcare needs. With the increase in market need for sanitizers and hand hygiene products, Medzone has created a new brand of products including hand sanitizing gel, hand sanitizing spray and foaming hand sanitizers in addition to Face Balm. Many of our formulations have been used for years by medical professionals. The Made in USA company is growing its Hygiene and Health Product category due to the increased need in the marketplace.

MedZone – http://www.medzonecorp.com

Face Balm – http://www.facebalm.com

Share article on social media or email:

Allterum Therapeutics granted Orphan Drug Designation and Rare Pediatric Disease Designation for its monoclonal antibody therapy for pediatric leukemia


Allterum Therapeutics, Inc. Logo

“We are eager to bring our antibody into clinical trials next year with the hope that we will see significant clinical benefit in children with relapsed ALL,” said Dr. Atul Varadhachary, Fannin Managing Partner and President of Allterum.

Allterum Therapeutics, Inc. has been granted both an Orphan Drug Designation and a Rare Pediatric Disease Designation by the FDA for its monoclonal antibody therapy under development for the treatment of pediatric acute lymphoblastic leukemia (ALL). These two designations highlight the medical need and research behind this program and pave the way for an expected Phase I clinical trial in 2021.

Orphan Drug Designation is granted by the FDA to promising new therapies which are being developed for rare indications in the United States. Similarly, Rare Pediatric Disease Designation is granted by the FDA to recognize programs which are specifically geared towards technologies for life-threatening diseases which primarily impact pediatric populations.

While many pediatric patients with ALL respond favorably to standard chemotherapeutics, a subset of patients experience relapsed or refractory disease. In particular, patients with relapsed T-cell ALL have no effective standard therapies available to them. Similarly, additional patients with a subtype of B-cell ALL may not be managed effectively with currently available therapies. Allterum’s antibody therapy is designed to be effective in these patient populations.

The technology was invented at the National Cancer Institute by Dr. Scott Durum and his colleagues. Allterum has received $2.9 million in funding from CPRIT (Cancer Prevention & Research Institute of Texas) and is scaling up its antibody for GMP manufacture with Fujifilm Diosynth Biotechnologies. Allterum is partnering with the TACL (Therapeutic Alliance for Children’s Leukemia) consortium for its Phase 1 program. The Chair and Vice-Chair of the TACL study are Dr. Eric Schafer (Baylor College of Medicine and Texas Children’s Hospital) and Dr. Susan Rheingold (Children’s Hospital of Philadelphia), respectively.

Allterum Therapeutics is currently completing remaining toxicology and scale-up manufacturing for its monoclonal antibody therapy. “Allterum remains on track to submit an Investigational New Drug (IND) application to the FDA in early 2021,” said Dr. Atul Varadhachary, Fannin Managing Partner and President of Allterum. “We are eager to bring our antibody into clinical trials next year with the hope that we will see significant clinical benefit in children with relapsed ALL.”

##

About Allterum

Founded in 2018, Allterum Therapeutics, Inc., is a bio-pharmaceutical company developing 4A10, a monoclonal antibody therapy for the treatment of pediatric acute lymphoblastic leukemia. Allterum Therapeutics is a spin-out company, founded through Fannin Innovation Studio.

About Fannin Innovation Studio

Houston-based Fannin Innovation Studio is an early-stage life sciences development group focused exclusively on commercializing biotech and medtech technologies. Fannin creates and manages startups to develop internal and in-licensed programs. To further bridge the commercialization gap, Fannin’s fellowship and internship programs provide aspiring entrepreneurs with hands-on development experience with its portfolio companies. For more information, visit http://www.FanninInnovation.com, come by the Studio at 3900 Essex Lane — Suite 575 in Houston, or email us at innovate@fannininnovation.com.

For More Information:

Serena Miggins

Fannin Innovation Studio

innovate@fannininnovation.com

713.966.5844

Share article on social media or email:

SAFER™ One Wins New Product of the Year Award for Industrial Hygiene Software


Real-time release monitoring and modeling with SAFER One changes the way organizations respond to chemical emergencies, giving them the power to drive safer outcomes for their people, plant, and nearby communities.

Industrial Scientific, a global leader in gas detection and connected safety, is pleased to announce that Occupational Health & Safety (OH&S) magazine’s panel of expert judges has named SAFER One the New Product of the Year for industrial hygiene software.

SAFER One is the only dynamic plume modeling software on the market that gives users real-time visibility into chemical releases so they can easily identify the source, severity, and community impact. SAFER One is often used by industrial hygienists and other safety personnel to track and respond to chemical releases, investigate community odor complaints, and simulate possible turnaround and shutdown scenarios.

“OH&S has been celebrating innovation and products optimized to keep workers safe for over 10 years. This year, safety products and services are being recognized on a global scale, bringing greater awareness to the important work completed by manufacturers in the industry,” OH&S Editor Sydny Shepard said. “Now more than ever, it is of the utmost importance to keep workers and employees safe from emerging and existing workplace hazards.”

“Real-time release monitoring and modeling with SAFER One changes the way organizations respond to chemical emergencies, giving them the power to drive safer outcomes for their people, plant, and nearby communities,” said Eric Fishman, director of strategic partnerships at Industrial Scientific. “We are elated that this panel of expert judges recognizes the power of SAFER One to change lives by reducing the number of workplace injuries and deaths due to chemical exposure.”

To learn more about SAFER One Dynamic Plume Modeling software, visit http://www.indsci.com/safer.

About Industrial Scientific Corporation

As a global leader in connected sensing technology, Industrial Scientific provides gas detection products, services and software to keep workers safe in hazardous environments. To date, the company supports 3,000 iNet® customers and monitors more than 375,000 devices across 13,500 sites. Established in 1985 and headquartered in Pittsburgh, Pennsylvania, Industrial Scientific has more than 1,200 global employees across 21 countries committed to preserving human life and eliminating death on the job by the year 2050. Industrial Scientific is also the parent company to Predictive Solutions Corporation (http://www.predictivesolutions.com) and Intelex Technologies (http://www.intelex.com). For more information, visit http://www.indsci.com.

Share article on social media or email:

Coral Genomics Awarded SBIR Grant to Advance Low-Depth Applications for Clinical Sequencing


Coral Genomics Logo

Coral Genomics Logo

Coral Genomics has been awarded a $2 million National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant to fund research that will expand the clinical utility of genomics for diverse populations. The results of the study will not only improve patient outcomes, but lower costs for health systems.

Specifically, the awarded grant aims to apply low depth applications for clinical germline sequencing, including low coverage whole genome sequencing (lcWGS) and whole exome sequencing (WES), through innovate library prep and analysis capabilities. Coral’s first study under the grant will focus on Inflammatory Bowel Disease (IBD) and yield data to help healthcare practitioners select the optimal therapeutic option for each patient, ending the current trial-and-error process that can take years to find the correct treatment.

The focus on diverse populations is due to the current lack of participation of minority populations in clinical studies, which has resulted in little available information upon which health practitioners can base selection of proper treatment of patients within a minority demographic.

Coral will process patient samples in its recently certified CLIA lab and use its algorithms to determine the best therapeutic for IBD patients. The company is currently in the clinical state of development and enrolling patients. Initial results will be available at the end of 2020, but the study will continue for 2 years to improve the quality of data collected.

Coral’s Phase II award follows a Phase I NIH SBIR grant to fund its innovative library preparation strategies. Since receiving the Phase I grant, Coral’s has extended its genomics workflows to include functional assays which improve medication selection predictions significantly across age, gender, and race compared to current practice.

Coral Genomics, founded in 2018 in San Francisco, California, generates novel data sets to fill gaps in large-scale biobanks with clinical diagnostics that facilitate medication selection for diverse populations. Integrating molecular, functional, and clinical factors to optimize treatment for chronic disease, Coral works with healthcare systems to provide end-to-end precision medicine support from next-generation sequencing through patient/provider facing healthcare reports that create more personalized and efficient healthcare delivery. Coral is fueled by the largest diverse database functionally associating genetic variation to clinical outcomes. Coral has recently been registered as a CLIA lab by California.

Share article on social media or email:

Advanced Radiation Therapy Announces the Launch of ConfidenceRT™


ConfidenceRT logo

ConfidenceRT- Discover What You Are Missing.

ConfidenceRT is the right product for this market at the right time.

ConfidenceRT™ has been launched in the U.S. MedTech marketplace and is available to radiation therapy clinics and hospitals immediately.

“We have been developing this technology for some time now and have designed it to meet the clinical challenges of treating breast cancer with radiation in ways which optimize the cosmetic and clinical outcomes in consideration of the adjuvant surgical techniques commonly employed today,” says Piran Sioshansi, President and CEO of Advanced Radiation Therapy (ART).

By leveraging the imaging quality of breast diagnostic technology, ConfidenceRT provides radiation oncologists with high-resolution images in real-time allowing them to both easily identify the tumor bed and treat patients quickly on a single platform. This approach provides a means to treat patients efficiently and can be deployed to maximize the ability to treat in a hypofractionation environment. In the new world of COVID-19 and considering reimbursement changes in the U.S. providing radiation oncology centers this clinical and operational flexibility is the right response.

Bill Dowd, Chief Commercialization Officer at ART, commented that “ConfidenceRT is the right product for this market at the right time. Approximately 12% of women will be diagnosed with breast cancer in their lifetime so novel technologies like this one are in ever-increasing demand as our population becomes larger and grows older.”

About Advanced Radiation Therapy (ART)

Advanced Radiation Therapy, headquartered outside of Boston, MA, is an innovator in precision radiation therapy for breast cancer and developed multiple non-invasive breast brachytherapy treatments (NIBB).

For more information visit http://www.ConfidenceRT.com and on LinkedIn.

For more information contact Bill Dowd (Bill.Dowd@artcorporation.net | 978-649-0007)

Share article on social media or email:

Introducing LeggUP’s Career Health Program Builder for Managers


LeggUP team building and enterprise career coaching solutions

LeggUP’s new Career Health Program Builder allows managers to go beyond team building to offer custom growth for their employees.

Managers are now able to better offer the growth and career support that the contemporary employee demands, in a way that fits into everyone’s schedule.

LeggUP, the 𝗰𝗮𝗿𝗲𝗲𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 for enterprises, has unveiled its newest tool for offering meaningful growth and development for employees at all levels of an organization: the Career Health Program Builder. Managers can now independently design, assemble, and deploy custom coaching options for teams of any size, right from within the LeggUP platform.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗖𝗮𝗿𝗲𝗲𝗿 𝗚𝗿𝗼𝘄𝘁𝗵

With the deployment of this program building platform, managers are empowered in a truly novel way. With LeggUP’s fully-developed modular ecosystem of 40 coaching topics, including Resilience, Learning Agility, Growth Mindset, & Managing Complexity, managers have the power to create targeted, custom, dialed-in career support for their teams. Coaching is performed in LeggUP’s virtual learning environment, with fully vetted, ICF-certified career coaches. Programs themselves are highly-customizable, with topics selected solely by managers, or options to allow employee choice for some sessions. Managers can even designate unique programs for individual members of their team. Flexible payment options and custom reporting are designed specifically to suit enterprise needs.

𝗧𝗵𝗲 𝗜𝗱𝗲𝗮𝗹 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗳𝗼𝗿 𝗧𝗼𝗱𝗮𝘆’𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗿

This flexible program approach uniquely addresses the pain points that managers face when working to support their teams, both onsite and remote.

● Learn how to lead remote workers and still improve productivity

● Managers know their employees desire support, but often run out of hours in the day to adequately provide individual professional development

● Self-starter employees are motivated and capable of change and growth, allowing enterprises to implement initiatives instantly.

𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗺𝗲𝗻𝘁, 𝗢𝗻 𝗗𝗲𝗺𝗮𝗻𝗱

With LeggUP, managers are now free to implement substantive professional development in a fraction of the time, while better matching the needs of each team member. Because the manager is in the driver’s seat, programs are meaningfully tailored to the objectives of the enterprise, while also matching the nuanced needs of individual team members.

LeggUP is there for the whole team:

● Empower team members wanting to grow in their career

● Take a substantial load off the shoulders of managers, while providing insight and data points for mid-year and end-of-year performance reviews

● Return time back to managers’ calendars to focus on the big picture, while coaches help teams pursue their individual career health goals

● Provide infinite flexibility for implementing programs, while managers enjoy improved reporting and oversight from the LeggUP dashboard

● Improve team culture and individual wellbeing, while also producing high-performing, better-communicating team members

LeggUP co-founder Tom Finn elaborated on how this new dimension of the LeggUP platform supports its mission. “At the center of a company’s culture are managers. Managers are now able to better offer the growth and career support that the contemporary employee demands, in a way that fits into everyone’s schedule. Simply put, managers can now get a more hands-on grasp of their team’s professional development activities.”

For more information on custom programs, visit leggup.com

𝗔𝗯𝗼𝘂𝘁 𝗟𝗲𝗴𝗴𝗨𝗣

LeggUP is a transformative career health platform that delivers employee experiences designed to accelerate the success of enterprises. Through 1-on-1 personal engagements, employees are equipped to thrive and grow in complex and dynamic environments. LeggUP is working to unlock the worlds potential.

Share article on social media or email: